Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide in Resistant Depression in Elderly Subjects
2024-517549-15-00Phase 3Completed
- Sponsor
- CHRU Tours
- Start
- Nov 2024
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitrous oxide + oxygen in treatment-resistant depression (TRD) (2 arms), sponsored by CHRU Tours. Primary endpoint: Change in MADRS Depression Severity Scale at Week 2. Started Nov 2024; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on 2024-517549-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517549-15-00.